Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Armata Pharmaceuticals Has Achieved Full Enrollment (N=50) Of Its Phase 1b/2a diSArm Study Of Intravenous AP-SA02 For Staphylococcus Aureus Bacteremia, Topline Data Is Expected In The First Quarter Of 2025

Author: Benzinga Newsdesk | November 12, 2024 08:14am

Posted In: ARMP